Intelligent Investor

Polynovo Limited (ASX: PNV) - Share Price and Research

Current share price for PNV : $1.945 0.115 (5.58%)

Polynovo Limited (PNV), an ASX-listed company, is involved in the development of f innovative medical devices for a number of medical applications, utilising the patented bioabsorbable polymer technology NovoSorb. The Company can manufacture NovoSorb polymer devices with the ability to elute drugs, antimicrobials as well as be expressed in a variety of physical formats including, Films, foam, Coatings/sprays ,Fibers ,Plastic structures ,Biologic carrier

PNV General Information +

ASX Code PNV
Website http://www.polynovo.com
Industry/Sector Health Care Supplies
Market Cap ($M) 1,342
PNV Share Price $1.945
Day High $2.035
Day Low $1.945
Last Close $2.060
PNV Share Price Movement $0.12 ( 5.58% )
Prices as at 16:40, 19 Apr 2024
+Security prices are delayed by at least 20 minutes and are indicative only.
Upsell Banner

PNV Related Research

Polynovo Limited (PNV) Upcoming Dividends & Yields

There are no dividends for Polynovo Limited (PNV). Please use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Polynovo Limited (PNV) Recent ASX Announcements

Headline Annoucement date/time+ Price at announcement+ Current price+ Price 7D Avg Gain/Loss
Notification regarding unquoted securities - PNV 10 Apr 2024 11:51AM $2.245 $1.945 $2.150 fallen by 13.36%
India update 4 Mar 2024 9:54AM $2.200 $1.945 $2.150 fallen by 11.59%
Webcast Recording - 1H24 Results 28 Feb 2024 3:52PM $2.120 $1.945 $2.150 fallen by 8.25%
  • + Company announcements and prices are delayed by at least 20 minutes. Prices are indicative only.

See all ASX announcements from Polynovo Limited (PNV) or use our ASX Announcements tool to search for announcements across all ASX-listed securities.

PNV Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2025F $10.56 $1.52 453.40% 127.96 0.00 0.00% 0.0%
2024F $1.91 $0.28 -135.30% 694.64 0.00 0.00% 0.0%
2023A -$5.35 -$0.78 2,113.00% -235.43 0.00 0.00% 0.0%

PNV Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2023 A 2024 F 2025 F 2023 A 2024 F 2025 F 2023 A 2024 F 2025 F
Ansell (ANN) $3,538M -0.0429 -0.1747 0.5862 14.3071 17.3351 10.9290 2.79% 2.34% 4.11%
Nanosonics (NAN) $842M 4.3197 -0.6317 1.1632 42.8351 116.3180 53.7718 0.00% 0.00% 0.00%
Polynovo (PNV) $1,422M 3.0000 0.0000 4.4286 0.0000 735.7143 135.5263 0.00% 0.00% 0.00%

PNV Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 2,275.00 20.50 22.10
Market 0.53 15.00 1.10 1.00
Sector 0.84 33.00 2.36 2.40

PNV Directors

Name Position Start Date
Mr Bruce Rathie Non-Executive Director 18 Feb 2010
Dr Robyn Elliott Non-Executive Director 28 Oct 2019
Mr Andrew Stuart Lumsden Non-Executive Director 4 Jun 2021
Mr Leon Hoare Non-Executive Director 27 Jan 2016
Ms Christine Emmanuel-Donnelly Non-Executive Director 13 May 2020
Mr David Williams Non-Executive Director, Non-Executive Chairman 28 Feb 2014

Polynovo Limited (PNV) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
31 Oct 2023 ELLIOTT, Robyn Buy Direct Shares 32,000 $1.190 $38,080.000
28 Jun 2023 ELLIOTT, Robyn Buy Direct Shares 27,000 $1.470 $39,690.000
8 Jun 2023 WILLIAMS, David Buy Indirect Shares 22,500 $1.600 $36,000.000

See all changes in directors' interest & trades for Polynovo Limited (PNV) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

PNV Management

Name Position
Swami Raote Chief Executive Officer
Jan-Marcel Gielen Chief Financial Officer,Company Secretary

PNV Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Polynovo Limited (PNV). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
72,331,050 (10.93%) HSBC Custody Nominees (Australia) Limited
46,707,261 (7.06%) J P Morgan Nominees Australia Pty Limited

PNV Calendar of Events

Date Event
25 February 2025 Report (Interim)
11 September 2024 Report (Annual)
21 August 2024 Report (Annual)
21 August 2024 Report (Prelim)

FAQs about Polynovo Limited (PNV)

Polynovo Limited's (PNV) current share price is $1.95. This constitutes a price movement of 9.53% when compared to the share price 7 days ago and is -21.89% below PNV's 12-month high of $2.49 per share. Prices are delayed by at least 20 minutes.

Relative to the previous close share price of $2.06, Polynovo Limited's (PNV) current share price of $1.95 constitutes a movement of -$0.12 or -5.58%. Polynovo Limited's (PNV) share price movement is -9.53% when compared to 7 days ago and is -21.89% below PNV's 52-week high of $2.49.

Polynovo Limited's (PNV) 52-week high is $2.49 which was reached on 13 Mar 2024. Relative to this, PNV's current share price of $1.95 constitutes a -$0.55 or -21.89% drop since that high of $2.49 per PNV share.

Polynovo Limited's (PNV) 52-week low is $1.12 which was reached on 20 Oct 2023. Relative to this, PNV's current share price of $1.95 constitutes a $0.83 or 73.66% gain since that low of $1.12 per PNV share.

Over the last 12 months, Polynovo Limited (PNV) has a daily average trading volume of 1,592,513 PNV shares per day.

Polynovo Limited (PNV) has a current dividend yield of n/a this year. Last year's dividend yield was 0%. The dividend yield for PNV is a ratio that tells you the percentage of Polynovo Limited's (PNV) share price that it pays out in dividends each year.

Polynovo Limited (PNV) has a franking level of 0%. Franking represents the tax Polynovo Limited (PNV) has already paid on any profit it distributes to shareholders as a dividend.

Polynovo Limited (PNV) will release its next Annual Report on 11 September 2024. Polynovo Limited's (PNV) last annual report was released on 13 Sep 2023. Click here to view Polynovo Limited's (PNV) last annual report.

Polynovo Limited (PNV) is classified as Health Care. Other companies in this sector include CSL Limited (CSL), Cochlear Limited (COH), ResMed Inc. (RMD), and Fisher & Paykel Healthcare Corporation Limited (FPH).

The price-to-earnings (P/E) ratio for Polynovo Limited (PNV) is 2275. The price-to-earnings ratio, also known as P/E ratio, P/E, or PER, is the ratio of Polynovo Limited's (PNV) share price to its earnings per PNV share.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.